Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: Sharbat-e-Banafsha: Dose will be administered orally, twice a day after meal for 21 days.the dose will be calculated according to age groups.
Age group 2-6 years 1/3 of adult dose = 1
Sponsors
Yogendra Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Symptoms persisted for more than 4 days per week or more than 4 weeks per year and at least one of the following rhinitis associated conditions such as nasal congestion, rhinorrhea sneezing and nasal itching 2. Patient guardian or parents willing to sign the informed consent form and follow the study protocol
Exclusion criteria
Exclusion criteria: 1. Patients suffering from congenital nasal abnormalities like nasal dermoid cysts, Deviated Nasal Septum, Atrophic rhinitis, Sinusitis, Hypertrophic turbinates, Adenoidal hypertrophy, foreign bodies 2. Patients has received systematically administered corticosteroids, antihistamines, decongestants or CAM therapy within 02 weeks prior to enrolment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in AEC & Serum IgETimepoint: 21 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Symptom Severity score and PGATimepoint: 21 Days | — |
Countries
India
Contacts
Public ContactYogendra Kumar
State Unani Medical College and Hospital
Outcome results
None listed